Tygh Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-15,896
Closed -$3.03M 98
2020
Q2
$3.03M Sell
15,896
-47,960
-75% -$8.4M 0.63% 69
2020
Q1
$9.9M Sell
63,856
-41,001
-39% -$4.77M 2.22% 8
2019
Q4
$8.78M Sell
104,857
-1,585
-1% -$121K 1.45% 30
2019
Q3
$7.21M Hold
106,442
1.28% 36
2019
Q2
$7.07M Buy
106,442
+9,553
+10% +$557K 1.2% 35
2019
Q1
$5.39M Buy
96,889
+15,745
+19% +$961K 0.95% 49
2018
Q4
$4.02M Buy
+81,144
New +$4.97M 0.84% 53

Other funds holding TDOC

Tygh Capital Management's TDOC Position: Q3 2020 in Review

Tygh Capital Management sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 15,896 shares — an estimated $3.03M sold.

Tygh Capital Management first reported a position in TDOC in Q4 2018 and held it in 7 quarters. The position peaked at $9.9M in Q1 2020. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • Tygh Capital Management reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
  • Tygh Capital Management sold 15,896 Teladoc Health shares in Q3 2020, an estimated $3.03M.
  • Tygh Capital Management first reported a position in Teladoc Health in Q4 2018 and held it in 7 quarters.
  • Tygh Capital Management's Teladoc Health position peaked at $9.9M in Q1 2020.
  • 743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Tygh Capital Management's 13F filing for Q3 2020, filed 5 Nov 2020.